Skip to main content
DOUBLE MEDICAL TECHNOLOGY INC. logo

DOUBLE MEDICAL TECHNOLOGY INC. — Investor Relations & Filings

Ticker · 002901 ISIN · CNE1000032W7 LEI · 836800DECKX5CGFNMD42 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 963 across all filing types
Latest filing 2023-05-26 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002901

About DOUBLE MEDICAL TECHNOLOGY INC.

https://www.double-medical.com

Double Medical Technology Inc. specializes in the development, manufacturing, and distribution of medical devices, with a primary focus on orthopedic solutions. The company's extensive product portfolio includes trauma fixation systems, spinal implants, joint prosthesis, and neurosurgical devices. Additionally, it provides specialized surgical instruments and advanced wound care products. Double Medical emphasizes research and innovation to deliver clinically effective solutions for complex musculoskeletal conditions. Its manufacturing processes adhere to international quality standards, ensuring the reliability of its implants and instruments used in hospitals and surgical centers worldwide. The company serves a global market, providing comprehensive support for orthopedic surgeons through its diverse range of reconstructive and regenerative medical technologies.

Recent filings

Filing Released Lang Actions
福建天衡联合律师事务所关于大博医疗科技股份有限公司2022年年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2022 Annual General Meeting (AGM) of a company. It details the convening and holding procedures of the AGM, the qualifications of attendees, the voting procedures, and the voting results for various proposals including the 2022 annual report and financial statements. The document is not the annual report itself but a legal opinion on the AGM process and resolutions. This fits the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of the AGM. The document length is sufficient and contains detailed voting results, not just an announcement of a report publication or a brief notice. Therefore, the correct classification is DVA with high confidence.
2023-05-26 Chinese
2022年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2022 Annual General Meeting Resolution Announcement" for the company 大博医疗科技股份有限公司. It details the date and method of the meeting, attendance, voting results on various proposals including the 2022 annual reports, profit distribution, audit firm reappointment, and other agenda items. It also includes a legal opinion confirming the legality and validity of the meeting and resolutions. The document is an official announcement of the voting results from the Annual General Meeting (AGM), not the full AGM materials or reports themselves. The length is about 4,098 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-05-26 Chinese
关于持股5%以上股东股份减持计划的预披露公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding a planned reduction in shareholding by a shareholder holding more than 5% of the company's shares. It details the shareholder's name, shareholding percentage, planned reduction amount, methods, timing, and compliance with relevant regulations. The document does not contain financial statements or detailed financial performance data but is a disclosure about a significant shareholder's intention to reduce holdings. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2023-05-23 Chinese
中信证券股份有限公司关于大博医疗科技股份有限公司2022年度定期现场检查报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2022年度定期现场检查报告" (2022 Annual On-site Inspection Report) issued by CITIC Securities Co., Ltd. regarding Dabao Medical Technology Co., Ltd. It details the on-site inspection covering governance, internal control, information disclosure, protection of company interests, use of raised funds, performance, shareholder commitments, and other important matters. The document includes detailed findings and compliance checks rather than just an announcement or summary. It is not an annual report (10-K), audit report (AR), or earnings release (ER), but rather a regulatory inspection report related to compliance and governance. Given the detailed nature and regulatory context, it fits best under Audit Report / Information (AR), which includes results of internal or regulatory inspections and applied accounting principles. The document length is under 5,000 characters but contains substantive content, so it is not a mere announcement (RPA). Therefore, the classification is AR with high confidence. FY 2022
2023-05-16 Chinese
中信证券股份有限公司关于大博医疗科技股份有限公司2022年度持续督导培训情况报告
Regulatory Filings Classification · 95% confidence The document is titled as a '2022年度持续督导培训情况报告' which translates to '2022 Annual Continuous Supervision Training Report' related to a company and its sponsor (中信证券). The content describes a training session conducted by the sponsor for the company's board, supervisors, and management to improve compliance and understanding of regulatory requirements. The document is short (1300 characters) and focuses on reporting the training event and its outcomes rather than presenting financial data or detailed financial results. It does not contain financial statements or substantive financial analysis. It is a report on a regulatory compliance training activity, which does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is also not a simple announcement of a report publication. The closest fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory-related reports that do not fit other categories.
2023-05-16 Chinese
中信证券股份有限公司关于大博医疗科技股份有限公司2022年度保荐工作报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2022年度保荐工作报告" which translates to "2022 Annual Sponsorship Work Report" by CITIC Securities for Dabao Medical Technology Co., Ltd. It details the sponsorship work overview, supervision of fundraising, governance oversight, internal controls, and regulatory compliance issues during the year 2022. It includes detailed descriptions of regulatory inspections, compliance with disclosure rules, and corrective actions taken. The document is a comprehensive report on the sponsor's activities and oversight related to the company for the year 2022. It is not an annual report of the company itself, nor is it a brief announcement or a certification. It is a detailed report on sponsorship work, which aligns with the category of Audit Report / Information (AR), as it involves regulatory oversight, compliance, and audit-related supervisory activities. The document length (4730 characters) is sufficient to be a full report rather than a mere announcement. Therefore, the best fitting classification is AR (Audit Report / Information). FY 2022
2023-05-16 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.